HOME >> MEDICINE >> NEWS
Penns Head Injury Center receives $110,000 NFL charities grant to study long-term effects of concussions

Knocking heads is part of the rough and tumble action of a football game, but few things can sideline an otherwise healthy athlete faster than a concussion. To study the long-term effects of concussions, NFL Charities, an organization of the member clubs of the National Football League, has awarded a $110, 000 grant to the Head Injury Center (HIC) of the University of Pennsylvania Medical Center.

Concussions have always plagued physical sports, where contact is part of the game. But football players, such as Troy Aikman and Steve Young, are only among the most visible of the two million Americans that suffer from traumatic brain injuries (TBIs) each year. People rarely associate concussions with what they really are traumatic brain injuries, said Tracy K. McIntosh, PhD, the Robert A. Groff Professor and Director of the HIC. Brain injury is a silent epidemic in this country, affecting more lives than most people realize.

In fact, the statistics surrounding traumatic brain injuries are staggering. According to numbers compiled by the Brain Injury Association, approximately 5.3 million Americans slightly more than 2% of the US population are living with a disability as a result of a severe brain injury. TBI is the leading cause of death and disability in persons under 45 years old, occurring more frequently than breast cancer, AIDS, multiple sclerosis, and spinal cord injury. Each year, approximately 100,000 people die from TBI, and 500,000 more are permanently disabled. Every 15 seconds, someone, usually a young person, suffers from a brain injury.

Despite these numbers, our understanding of the brains long-term response to injury is still incomplete. A brain-injured patient may look stable, but cells are still dying. Realizing this is important developing ways to recover, regenerate, and stem the loss of brain tissue, said McIntosh. We hope that by understanding the molecular and cellular sequences of events after trauma, well be able t
'"/>

Contact: Greg Lester
lesterg@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
23-Jan-2001


Page: 1 2

Related medicine news :

1. University of Pennsylvania Health System launches life-saving eICU technology
2. The Hospital of the University of Pennsylvania evaluates heart failure treatments for landmark study
3. New project will develop cancer maps for Pennsylvania
4. Pennsylvania chemist wins national award for pharmaceutical research
5. Gender bias in salaries among Pennsylvania M.D.s, find University of Pittsburgh researchers
6. Wistar Institute Facility distinguished as center of excellence by Ben Franklin Technology PArtners of Southeastern Pennsylvania for second year
7. Idaho attorney, Pennsylvania physician to lead American Heart Association in 1999-2000
8. Pennsylvania voters believe tobacco settlement funds should be used for cancer research
9. Injury toll in US homes tops 12 million yearly: UNC, other experts call for action
10. Injury from epileptic seizures relatively rare, Mayo Clinic study find
11. Injury death rate for Canadian farm children aged 1-6 higher than national average

Post Your Comments:
(Date:4/27/2015)... (PRWEB) April 27, 2015 Covenant Care, ... nationwide, has rolled out its “Enhanced Dining” service with ... foods developed with input from residents, patients and families ... and the redesign of its dining rooms so that ... the quality of life for our residents is our ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 The ... both inpatient and outpatient therapy facilities that provide physical, ... years to 2015, the industry has experienced revenue growth ... acceptance of the benefits of physical therapy services. The ... helped support industry revenue growth during the period because ...
(Date:4/26/2015)... Indiana Fiber Network, LLC (IFN), the leading Indiana ... Company has selected IFN as a fiber transport provider. ... Mutual Insurance Company states: “IFN’s broadband fiber solution created ... We were interested in building entrance and ... ensure we achieved both. ” , According ...
(Date:4/26/2015)... India Network Foundation, a non-profit organization in ... to the Asian Indian community in the United States ... than two decades. The India News Network Digest of ... the world with the latest news items from India, ... Law Forum Digest, edited and contributed by Sheela Murthy, ...
(Date:4/26/2015)... The grand celebration got off to a festive start with ... Deb then introduced Sandy Valentine, the wife of CCAR’s Executive ... his Walk for Recovery on the Appalachian Trail. ... gratitude to the volunteers via video. Board President Tom Kirk ... CCAR’s mission. Volunteer Manager Conrad Sienkiewicz read the names ...
Breaking Medicine News(10 mins):Health News:Covenant Care Rolls Out "Enhanced Dining" Offering Restaurant Style Experience To Residents, Patients & Families 2Health News:Physical Therapy Rehabilitation Centers in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Physical Therapy Rehabilitation Centers in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 3Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 2Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 3Health News:The Connecticut Community for Addiction Recovery (CCAR) honors its volunteers during National Volunteer Recognition Week. 2
(Date:4/24/2015)... -- Hospira, Inc. (NYSE: HSP ), ... spoke about the importance of extrapolation in bringing biosimilars ... annual European Biosimilars Group conference in London ... publication of a pivotal white paper titled, "Why ... biosimilars." Speaking at the EGA conference, ...
(Date:4/23/2015)... , April 24, 2015  AbbVie (NYSE: ABBV ... Administration (FDA) has accepted its New Drug Application (NDA) ... two direct-acting antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), ... of adults with chronic genotype 4 (GT4) hepatitis C ... first all-oral, interferon-free therapy being evaluated by the FDA ...
(Date:4/23/2015)... 23, 2015 Once again, BeaconMedaes is meeting ... to patient safety. BeaconMedaes, priority is to ... disease. The next generation Zone Valve Box ... are now mounted in the assembly, allowing for ease ... ceiling tiles potentially releasing dust spores and other bacteria ...
Breaking Medicine Technology:Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7BeaconMedaes launches new Zone Valve Box Assembly 2
Cached News: